Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-13

Clinical Trial Update: Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide with gemcitabine in untreated advanced pancreatic cancer; results were posted on March 13, 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemzar (gemcitabine)
  • Revlimid (lenalidomide)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-03-13